Answers are grounded in this paper and cite their sources.
Reports the trial design and baseline characteristics in ambulatory heart failure, evaluating the safety of hypertonic saline solution with loop diuretics.
Hypertonic saline solution (HSS) plus intravenous (IV) loop diuretic appears to enhance the diuretic response in patients hospitalized for heart failure (HF). The efficacy and safety of this therapy in the ambulatory setting have not been evaluated. We aimed to describe the design and baseline characteristics of the SALT-HF trial participants.
No takes yet. Share an insight, caveat, or question.
Marcos et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: